[18F]PSMA-1007 PET/CT in the detection of neoplastic lumbosacral plexopathy as an emerging and underestimated spread of prostate cancer

被引:1
|
作者
Deleu, A. -L. [1 ]
Ahmadi Bidakhvidi, N. [1 ,2 ]
Van Wynsberge, L. [3 ]
Van Laere, K. [1 ,2 ]
De Meerleer, G. [4 ]
Goffin, K. [1 ,2 ]
机构
[1] Univ Hosp Leuven, Dept Nucl Med, Leuven, Belgium
[2] Katholieke Univ Leuven, Nucl Med & Mol Imaging, Dept Imaging & Pathol, Leuven, Belgium
[3] Tienen Reg Hosp, Dept Urol, Tienen, Belgium
[4] Univ Hosp Leuven, Dept Radiat Oncol, Leuven, Belgium
关键词
D O I
10.1007/s00259-022-05828-3
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:3950 / 3951
页数:2
相关论文
共 50 条
  • [1] [18F]PSMA-1007 PET/CT in the detection of neoplastic lumbosacral plexopathy as an emerging and underestimated spread of prostate cancer
    A.-L. Deleu
    N. Ahmadi Bidakhvidi
    L. Van Wynsberge
    K. Van Laere
    G. De Meerleer
    K. Goffin
    European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 3950 - 3951
  • [2] Biochemical Recurrence of Prostate Cancer: Initial Results with [18F]PSMA-1007 PET/CT
    Giesel, Frederik L.
    Will, Leon
    Kesch, Claudia
    Freitag, Martin
    Kremer, Christophe
    Merkle, Jonas
    Neels, Oliver C.
    Cardinale, Jens
    Hadaschik, Boris
    Hohenfellner, Markus
    Kopka, Klaus
    Haberkorn, Uwe
    Kratochwil, Clemens
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (04) : 632 - 635
  • [3] Diagnostic accuracy of [18F]PSMA-1007 PET/CT in biochemical recurrence of prostate cancer
    Clemens Mingels
    Karl Peter Bohn
    Axel Rominger
    Ali Afshar-Oromieh
    Ian Alberts
    European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 2436 - 2444
  • [4] Diagnostic accuracy of [18F]PSMA-1007 PET/CT in biochemical recurrence of prostate cancer
    Mingels, Clemens
    Bohn, Karl Peter
    Rominger, Axel
    Afshar-Oromieh, Ali
    Alberts, Ian
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (07) : 2436 - 2444
  • [5] The Role of 18F PSMA-1007 PET/CT in the Staging and Detection of Recurrence of Prostate Cancer, A Scoping Review
    Armany, David
    Vo, Lequang
    Self, Duncan
    Baskaranathan, Sriskanthan
    Hossack, Tania
    Bariol, Simon
    Ende, David
    Woo, Henry Hyunshik
    CANCERS, 2025, 17 (06)
  • [6] [18F]PSMA-1007 PET for biochemical recurrence of prostate cancer, a comparison with [18F]Fluciclovine
    Loeff, Cato C.
    van Gemert, Willemijn
    Prive, Bastiaan M.
    van Oort, Inge M.
    Hermsen, Rick
    Somford, Diederik M.
    Nagarajah, James
    Heijmen, Linda
    Janssen, Marcel J. R.
    EJNMMI REPORTS, 2024, 8 (01)
  • [7] Assessment of urinary bladder activity and detection of local prostate cancer lesions in [18F]PSMA-1007 PET/CT
    Krieger, K.
    Afshar-Oromieh, A.
    Rominger, A. O.
    Alberts, I. L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S484 - S485
  • [8] Role of volumetric parameters on [18F]PSMA-1007 PET/CT in primary staging of prostate cancer
    Castello, A.
    Farulla, L. Airo
    Longari, V.
    Orunesu, E.
    Schiavini, M.
    Bardo, F.
    Arnaboldi, M.
    Galli, E.
    Florimonte, L.
    Castellani, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S488 - S488
  • [9] Optimization of [18F]PSMA-1007 PET-CT using regularized reconstruction in patients with prostate cancer
    Elin Trägårdh
    David Minarik
    Gustav Brolin
    Ulrika Bitzén
    Berit Olsson
    Jenny Oddstig
    EJNMMI Physics, 7
  • [10] Risk of metastatic disease using [18F]PSMA-1007 PET/CT for primary prostate cancer staging
    Chikatamarla, Venkata Avinash
    Okano, Satomi
    Jenvey, Peter
    Ansaldo, Alexander
    Roberts, Matthew J.
    Ramsay, Stuart C.
    Thomas, Paul A.
    Pattison, David A.
    EJNMMI RESEARCH, 2021, 11 (01)